Immunogenicity of an Additional mRNA-1273 SARS-CoV-2 Vaccination in People With HIV With Hyporesponse After Primary Vaccination

Autor: Marlou J Jongkees, Daryl Geers, Kathryn S Hensley, Wesley Huisman, Corine H GeurtsvanKessel, Susanne Bogers, Lennert Gommers, Grigorios Papageorgiou, Simon P Jochems, Jan G den Hollander, Emile F Schippers, Heidi S M Ammerlaan, Wouter F W Bierman, Marc van der Valk, Marvin A H Berrevoets, Robert Soetekouw, Nienke Langebeek, Anke H W Bruns, Eliane M S Leyten, Kim C E Sigaloff, Marit G A van Vonderen, Corine E Delsing, Judith Branger, Peter D Katsikis, Yvonne M Mueller, Rory D de Vries, Bart J A Rijnders, Kees Brinkman, Casper Rokx, Anna H E Roukens

Publikováno v: The Journal of Infectious Diseases, 227(5), 651-662. OXFORD UNIV PRESS INC
The Journal of Infectious Diseases, 227(5), 651-662. Oxford University Press
Jongkees, M J, Geers, D, Hensley, K S, Huisman, W, GeurtsvanKessel, C H, Bogers, S, Gommers, L, Papageorgiou, G, Jochems, S P, den Hollander, J G, Schippers, E F, Ammerlaan, H S M, Bierman, W F W, van der Valk, M, Berrevoets, M A H, Soetekouw, R, Langebeek, N, Bruns, A H W, Leyten, E M S, Sigaloff, K C E, van Vonderen, M G A, Delsing, C E, Branger, J, Katsikis, P D, Mueller, Y M, de Vries, R D, Rijnders, B J A, Brinkman, K, Rokx, C & Roukens, A H E 2023, ' Immunogenicity of an Additional mRNA-1273 SARS-CoV-2 Vaccination in People With HIV With Hyporesponse After Primary Vaccination ', The Journal of infectious diseases, vol. 227, no. 5, pp. 651-662 . https://doi.org/10.1093/infdis/jiac451
The Journal of infectious diseases, 227(5), 651-662. Oxford University Press

BackgroundThe COVIH study is a prospective coronavirus disease 2019 (COVID-19) vaccination study in 1154 people with HIV (PWH), of whom 14% showed reduced antibody levels after primary vaccination. We evaluated whether an additional vaccination boost

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::212f4cb5bd26595f95b402b24185a8e9
https://doi.org/10.1093/infdis/jiac451

Incidence of a first venous thrombotic event in people with HIV in the Netherlands

Autor: M. van der Valk, M.E.E. van Kasteren, Frank P. Kroon, Casper Rokx, M. Hillebregt, M.E. van der Ende, Selwyn H. Lowe, Emile F. Schippers, Jaime F Borjas Howard, S. Zaheri, J. W. Mulder, J. G. Den Hollander, Peter Reiss, Elise D. Pieterman, E. H. Gisolf, Bart J. A. Rijnders, Eliane M. S. Leyten, Colette Smit, Karina Meijer, Ferdinand W. N. M. Wit, Wouter F W Bierman, Kees Brinkman, Y. I. G. Vladimir Tichelaar

Publikováno v: The Lancet HIV, 6(3), e173-e181. Elsevier Limited
The Lancet, 6(3), e173-e181. ELSEVIER SCIENCE INC
LANCET HIV, 6(3), e173-e181. Elsevier Ltd.

BACKGROUND: The risk of venous thrombotic events is elevated in people with HIV, but overall risk estimates and estimates specific to immune status and antiretroviral medication remain i mprecise. In this study, we aimed to estimate these parameters

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::43410677a323dadc549556f896ef9b8d
https://doi.org/10.1016/s2352-3018(18)30333-3

Immune reconstitution inflammatory syndrome in HIV infected late presenters starting integrase inhibitor containing antiretroviral therapy

Autor: Eliane M. S. Leyten, Ferdinand W. N. M. Wit, Casper Rokx, Anneloes M Postma, Andy I. M. Hoepelman, Marjo E. E. van Kasteren, Ingeborg E A Wijting, Ghariba Bouchtoubi, Vera C M Bloemen, Kees Brinkman, Bart J. A. Rijnders, Marchina E. van der Ende, Peter Reiss, Wouter F W Bierman, Selwyn H. Lowe

Publikováno v: EClinicalMedicine
EClinicalMedicine, 17:100210. Lancet Publishing Group
EClinicalMedicine, 17:100210. Elsevier
EClinicalMedicine, Vol 17, Iss, Pp-(2019)
EClinicalMedicine, 17. Elsevier

Background: Integrase inhibitors (INI) induce a rapid decline of HIV-RNA in plasma and CD4+ T-cell recovery in blood. Both characteristics are also associated with immune reconstitution inflammatory syndrome (IRIS). Whether the use of INI-containing

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5c499d532107a80a8b99a7469894064c
https://doi.org/10.1016/j.eclinm.2019.11.003

Disparities in access to and use of HIV-related health services in the Netherlands by migrant status and sexual orientation: A cross-sectional study among people recently diagnosed with HIV infection

Autor: Debora Alvarez-del Arco, Jan M. Prins, Kees Brinkman, Janneke P. Bil, Fiona Burns, Maria Prins, Freke R Zuure, Ard van Sighem, Eliane M. S. Leyten

Publikováno v: BMC Infectious Diseases
Repisalud
Instituto de Salud Carlos III (ISCIII)
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-13 (2019)
BMC infectious diseases, 19(1):906. BioMed Central

BACKGROUND: Migrants often face barriers to accessing healthcare. We examined disparities in access to and use of HIV-related health services between migrant and non-migrant people recently diagnosed with HIV living in the Netherlands, taken into acc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f01a405b3079469bbaaacd8012709a56
https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85074344729&origin=inward

Borderline QuantiFERON results and the distinction between specific responses and test variability

Autor: Jonathan W. Uzorka, Sandra M. Arend, Willeke P. J. Franken, Ailko W. J. Bossink, Alida C. van Haeften, Eliane M. S. Leyten, Peter Boonstra, Tom H. M. Ottenhoff, Gert Doornenbal, Steven Thijsen

Publikováno v: Tuberculosis, 111, 102-108

QuantiFERON (QFT) results near the cut-off are subject to debate. We aimed to investigate which borderline QFT results were due to Mycobacterium tuberculosis (Mtb)-specific responses or to test variability.In a contact investigation, tuberculin skin

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::49d89064a884b9c26d5c966a3ccf3933
https://hdl.handle.net/1887/75251